nucala
glaxosmithkline nz limited - mepolizumab 144mg ((100 mg/ml after reconstitution with 1.2 ml of wfi, delivers 1 ml)) - powder for injection - 100 mg/ml - active: mepolizumab 144mg ((100 mg/ml after reconstitution with 1.2 ml of wfi, delivers 1 ml)) excipient: dibasic sodium phosphate heptahydrate hydrochloric acid polysorbate 80 sucrose - nucala is indicated as an add-on treatment for severe eosinophilic asthma in patients aged 12 years and over.
ag-dutasteride capsule
angita pharma inc. - dutasteride - capsule - 0.5mg - dutasteride 0.5mg - 5 alfa reductase inhibitors
3tc tablets 150mg
glaxosmithkline pharmaceutical sdn. bhd. - lamivudine -
zeffix tablet 100mg
glaxosmithkline pharmaceutical sdn. bhd. - lamivudine -
ziagen tablet
glaxosmithkline pharmaceutical sdn. bhd. - abacavir sulfate -
avodart soft gelatin capsules
glaxosmithkline pharmaceutical sdn. bhd. - dutasteride -
kivexa tablets
glaxosmithkline pharmaceutical sdn. bhd. - lamivudine; abacavir sulfate -
panadol cold+flu-d caplet
glaxosmithkline consumer healthcare sdn. bhd. - paracetamol; phenylephrine hcl; chlorpheniramine maleate -
panadol soluble tablet 500mg
glaxosmithkline consumer healthcare sdn. bhd. - paracetamol -
panadol actifast caplet
glaxosmithkline consumer healthcare sdn. bhd. - paracetamol -